TP53 and glioblastoma: Sox4 has also been reported to inhibit the cell growth of glioblastoma multiforme (GBM) by mediating G0/G1 cell cycle arrest via Akt-p53 pathway and therefore is considered to be a positive prognostic biomarker of primary GBMs [90].